These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11154803)

  • 21. Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986).
    Giagheddu M; Puggioni G; Sanna G; Tamburini G; Marrosu F; Rachele MG; Murgia B; Rosati G
    Acta Neurol Scand; 1989 Apr; 79(4):326-33. PubMed ID: 2728857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data.
    Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L
    Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology of myasthenia gravis in central and western Virginia.
    Phillips LH; Torner JC; Anderson MS; Cox GM
    Neurology; 1992 Oct; 42(10):1888-93. PubMed ID: 1407568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of Myasthenia Gravis in Slovakia in the Years 1977-2015.
    Martinka I; Fulova M; Spalekova M; Spalek P
    Neuroepidemiology; 2018; 50(3-4):153-159. PubMed ID: 29558746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological study of myasthenia gravis in the province of Ferrara, Italy.
    Tola MR; Granieri E; Paolino E; Caniatti L; Quatrale R; Mazzanti B; D'Alessandro R
    J Neurol; 1989 Oct; 236(7):388-90. PubMed ID: 2809639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of myasthenia gravis in Antioquia, Colombia].
    Sánchez JL; Uribe CS; Franco AF; Jiménez ME; Arcos-Burgos OM; Palacio LG
    Rev Neurol; 2002 Jun 1-15; 34(11):1010-2. PubMed ID: 12134295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myasthenia gravis incidence in a general North Atlantic isolated population.
    Joensen P
    Acta Neurol Scand; 2014 Oct; 130(4):222-8. PubMed ID: 24981565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979-2008.
    Lavrnic D; Basta I; Rakocevic-Stojanovic V; Stevic Z; Peric S; Nikolic A; Marjanovic I; Pekmezovic T
    Neuroepidemiology; 2013; 40(3):190-4. PubMed ID: 23363926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009.
    Pedersen EG; Hallas J; Hansen K; Jensen PE; Gaist D
    Eur J Neurol; 2013 Feb; 20(2):309-14. PubMed ID: 22882327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis: a higher than expected incidence in the elderly.
    Aragonès JM; Bolíbar I; Bonfill X; Bufill E; Mummany A; Alonso F; Illa I
    Neurology; 2003 Mar; 60(6):1024-6. PubMed ID: 12654975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia gravis in the county of Viborg, Denmark.
    Sørensen TT; Holm EB
    Eur Neurol; 1989; 29(3):177-9. PubMed ID: 2731568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
    Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
    Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of myasthenia gravis in Norway.
    Storm-Mathisen A
    Acta Neurol Scand; 1984 Oct; 70(4):274-84. PubMed ID: 6507037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and epidemiological features of myasthenia gravis in Chilean population.
    Cea G; Martinez D; Salinas R; Vidal C; Hoffmeister L; Stuardo A
    Acta Neurol Scand; 2018 Oct; 138(4):338-343. PubMed ID: 29845611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nationwide population-based epidemiological study of myasthenia gravis in taiwan.
    Lai CH; Tseng HF
    Neuroepidemiology; 2010; 35(1):66-71. PubMed ID: 20523074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myasthenia gravis (MG): epidemiological data and prognostic factors.
    Mantegazza R; Baggi F; Antozzi C; Confalonieri P; Morandi L; Bernasconi P; Andreetta F; Simoncini O; Campanella A; Beghi E; Cornelio F
    Ann N Y Acad Sci; 2003 Sep; 998():413-23. PubMed ID: 14592909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.
    Robertson NP; Deans J; Compston DA
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):492-6. PubMed ID: 9771771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy.
    Guidetti D; Sabadini R; Bondavalli M; Cavalletti S; Lodesani M; Mantegazza R; Cosi V; Solime F
    Eur J Epidemiol; 1998 Jun; 14(4):381-7. PubMed ID: 9690757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease.
    Yu YL; Hawkins BR; Ip MS; Wong V; Woo E
    Acta Neurol Scand; 1992 Aug; 86(2):113-9. PubMed ID: 1414218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
    Somnier FE
    Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.